by Corina Milic | Jul 29, 2026
How do we maintain access to life-saving HIV care and introduce a new wave of innovative tools as major funding cuts threaten to unravel decades of progress? A market under strain For over a decade, much of the donor-supported HIV market has benefited from...
by Scott Miller | Jul 27, 2026
CHAI is pleased to release Lessons from a decade of progress: reigniting momentum for hepatitis C elimination, a new report marking ten years of CHAI-supported hepatitis C programs in Cambodia, India, Indonesia, Myanmar, Nigeria, Rwanda, and Vietnam. Since 2016, these...
by Scott Miller | Jul 24, 2026
Lead exposure is one of the most widespread and overlooked threats to child health. CHAI and Renaissance Philanthropy have published a consensus Target Product Profile (TPP) that defines what a rapid, low-cost blood lead level test should deliver, to accelerate the...
by Scott Miller | Jul 17, 2026
Updated Sep. 1, 2026: CHAI and its partners have developed an FAQ document to aid stakeholders in understanding the details of the products, the agreement terms, and the potential benefits for TB programs. View the FAQ here. New agreements with DeepTek and Delft...
by Scott Miller | Jul 15, 2026
This is the current list of sessions with CHAI participation at AIDS 2026, which will take place virtually and in-person in Rio de Janeiro, Brazil from July 26 to 31, 2026. Please note that this page is continuously being updated as participants and sessions are...
by Scott Miller | Jul 9, 2026
The Clinton Health Access Initiative, the Agency Fund, and Endless Network have launched the AI Commons for Global Health, a new, shared initiative to ensure that as AI transforms healthcare, it works for the patients who need it most. The initiative emerged from a...
by Scott Miller | Jul 2, 2026
CHAI is pleased to release the 2026 Hepatitis C Treatment Market Memo, the latest in our series of hepatitis C market intelligence publications. A decade ago, curing hepatitis C cost more than US$84,000 per patient. Today, the same cure can be procured at around US$60...
by Scott Miller | Jun 22, 2026
Updated analysis from CHAI tracks the state of African vaccine manufacturing ambitions in 2026 Africa has long relied on other parts of the world for its vaccines, a vulnerability COVID-19 made impossible to ignore. That crisis galvanized African leaders and...
by Scott Miller | Jun 8, 2026
A year after global HIV funding was upended, the damage is still mounting. New nationwide data collected by CHAI across countries in sub-Saharan Africa and Asia tracks what happened to HIV services in 2025 and into early 2026 against the year before — and shows that...
by Scott Miller | May 18, 2026
An assessment of the regional vaccine manufacturing ecosystem across the region, the structural risks to its long-term viability, and targeted recommendations to strengthen it Across Southeast Asia, there is genuine will to build a regional vaccine manufacturing base...
